Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate | Patent Number 06965027

US 06965027 B2
Application Number10310078
Publication NumberUS 20030130292 A1
Pendency2 years, 11 months, 17 days
Filled DateDec 4, 2002
Priority DateDec 6, 2001
Publication DateJul 10, 2003
Expiration DateDec 6, 2021
Inventor/ApplicantsZheng J. Li
Zheng J. Li
Mark E. Flanagan
Mark E. Flanagan
ExaminesMCKENZIE, THOMAS C
Art Unit1624
Technology Center1600
Assignments
Pfizer Legal Division 2
Current
Pfizer Legal Division 2Pfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.